SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Misonix Inc. (MSON)
MSON 26.540.0%Nov 22 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: cape radical who wrote (510)10/31/1997 11:16:00 AM
From: Petemeister   of 947
 
In the end, profitability always determines the value of an equity. Short-term, many other factors move the price around. This quarter was by far the best September quarter MSON has ever posted from both a revenue and earnings standpoint. Remember that sales and net have been historically somewhat cyclical with the first quarter always being the worst. Sequential growth will not be flat. The thing I would be more worried about is the dilution to earnings from additional shares. Does anyone know more? Where are they coming from? How many to come? Company plans for the money? Solid growth at 20% or higher from this level of earnings means MSON is definitely undervalued but only if we don't end up spreading the new earnings over ten gazillion shares. One other thing. The tax rate looks a little low, about 25% of the net. Probably had some carry-forwards to apply yet last quarter. Future earning projections would probably have to take into account a slightly higher tax rate.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext